Evidence-Based Behavioral Medicine: What Is It and How Do We Achieve It?

Annals of Behavioral Medicine

Volumn 26, Issue 3, 2003, Pages 161-171

  Davidson, Karina W ^a,j   Goldstein, Michael ^b   Kaplan, Robert M ^c   Kaufmann, Peter G ^d   Knatterud, Genell L ^e   Orleans, C Tracy ^f   Spring, Bonnie ^g   Trudeaum, Kimberlee J ^h   Whitlock, Evelyn P ⁱ  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Institute for Health Care Communication Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Natl Heart Lung/Blood Institute   (United States)

^e MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^f ROBERT WOOD JOHNSON FOUNDATION   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h CITY UNIVERSITY OF NEW YORK   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j College of Physicians and Surgeons ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH BEHAVIOR; HEALTH CARE QUALITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; WELLBEING;

EID: 0346937475     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15324796ABM2603_01     Document Type: Review

References (39)

1. Moher D, Schulz KF, Altman DG, for the CONSORT Group: The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Medical Association. 2001, 285:1987-1991.
2. Eddy DM: Evidence-based clinical improvements. Presentation at Directions for Success: Evidence-Based Health Care Symposium sponsored by Group Health Cooperative, Tucson, AZ, 2001.
3. Sox Jr. HC, Woolf SH: Evidence-Based Practice Guidelines from the U.S. Preventive Services Task Force. Journal of the American Medical Association. 1993, 169(20):2678.
4. Woolf SH, Atkins DA: The evolving role of prevention in health care: Contributions of the U.S. Preventive Service Task Force. American Journal of Preventive Medicine. 2001, 29(Supp. 3):13-20.
5. Cook DJ, Greengold NL, Ellrodt G, Weingarten SR: The relation between systematic reviews and practice guidelines. Annals of Internal Medicine. 1997, 127:210-216.
6. Cook DJ, Mulrow CD, Haynes RB: Systematic reviews: Synthesis of best evidence for clinical decisions. Annals of Internal Medicine. 1997, 126(5):376-380.
7. Meade TW, Wald N, Collins R: CONSORT Statement on the reporting standards of clinical trials. BMJ. 1997, 314:1126.
8. Altman DG, Schulz KF, Moher D, et al.: The revised CONSORT Statement for reporting randomized trials: Explanation and elaboration. Annals of Internal Medicine. 2001, 134:663-694.
9. Rennie D: CONSORT revised: Improving the reporting of randomized trials. Journal of the American Medical Association. 2001, 285(15):2006-2007.
10. Whitlock EP, Orleans CT, Pender N, Allan J: Evaluating primary care behavioral counseling interventions: An evidence-based approach. American Journal of Preventive Medicine. 2002, 22(4):267-284.
11. Pigone MP, Ammerman A, Fernandez L, et al.: Counseling to promote a healthy diet in adults: A summary of the U.S. Preventive Services Task Force. American Journal of Preventive Medicine. 2003, 24(1):75-92.
12. U.S. Preventive Services Task Force: Behavioral counseling in primary care to promote physical activity: Recommendation and rationale. Annals of Internal Medicine. 2002, 137:205-207.
13. Diabetes Prevention Program Research Group: The Diabetes Prevention Program: Design and methods for clinical trial in the prevention of Type 2 diabetes. Diabetes Care. 1999, 22:623-634.
14. Institute of Medicine (U.S.) Committee on Health and Behavior: Research Practice and Policy: Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences. Washington, DC: National Academy Press, 2001.
15. Kaplan RM: The Ziggy theorem: Toward an outcomes-focused health psychology. Health Psychology. 1994, 13(6):451-460.
16. Kaplan RM: Two pathways to prevention. American Psychologist. 2000, 55(4):382-396.
17. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. Journal of the American Medical Association. 1996, 276(15):1253-1258.
18. Harris RP, Helfand M, Woolf SH: Current methods of the U.S. Preventive Services Task Force. American Journal of Preventive Medicine. 2001, 29(Supp. 3):21-35.
19. Peto R, Pike MC, Armitage P, et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I. Introduction and design. British Journal of Cancer. 1976, 34(6):585-612.
20. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials (3rd Ed.). New York: John Wright PSG Inc., 1998.
21. Pocock S: Clinical Trials: A Practical Approach. London: Wiley, 1983.
22. Coronary Drug Project Research Group: Practical aspects of decision making in clinical trials: The Coronary Drug Project as a case study. Controlled Clinical Trials. 1981, 1(4):363-376.
23. Peto R, Collins R, Gray R: Large-scale randomized evidence: Large, simple trials and overviews of trials. Journal of Clinical Epidemiology. 1995, 48(1):23-40.
24. Yusuf S, Collins R, Peto R, et al.: Intravenous and intracoronary fibrinolytic therapy in acute infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. European Heart Journal. 1985, 6(7):556-585.
25. Meinert CL: Clinical Trials: Design, Conduct and Analysis. New York: Oxford University Press, 1983.
26. Kunz R, Oxman AD: The unpredictability paradox: Review of empirical comparisons of randomized and non-randomized clinical trials. BMJ. 1998, 317(7167):1185-1190.
27. Clarke M, Oxman AD (eds): Cochrane Reviewers Handbook 4.2.0 [updated March 2003]. In The Cochrane Library, Issue 2, 2003. Oxford: Update Software.
28. Glassman AH, O'Connor CM, Califf RM, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association. 2002, 288(6):701-709.
29. Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD): Study design and methods. The ENRICHD investigators. American Heart Journal. 2000, 139(1, Pt 1):1-9.
30. Glasgow RE, Whitlock EP, Eakin EG, Lichtenstein E: A brief smoking cessation intervention for women in low-income Planned Parenthood clinics. American Journal of Public Health. 2000, 90(5):786-789.
31. Green SB, Corle DK, Gail MH, et al.: Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. American Journal of Epidemiology. 1995, 142(6):587-593.
32. Hollis S, Campbell F: What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ. 1999, 319:670-674.
33. Greenhalgh T: Assessing the methodological quality of published papers. BMJ. 1997, 315:305-308.
34. Robinson LA, Berman JS, Neimeyer RA: Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research. Psychological Bulletin. 1990, 108(1):30-49.
35. Smith ML, Glass GV, Miller TI: The Benefits of Psychotherapy. Baltimore, MD: The Johns Hopkins University Press, 1980.
36. Gaffan EA, Tsaousis I, Kemp-Wheeler SM: Research allegiance and meta-analysis: The case of cognitive therapy for depression. Journal of Consulting and Clinical Psychology. 1995, 63(6):966-980.
37. Moncher FJ, Prinz RJ: Treatment fidelity in outcome studies. Clinical Psychology Review. 1991, 11:247-266.
38. Lichstein KL, Riedel BW, Grieve R: Fair tests of clinical trials: A treatment implementation model. Advanced Behavioral Research Therapy. 1994, 16:1-29.
39. McGrath PJ, Stinson J, Davidson K: Commentary: The Journal of Pediatric Psychology should adopt the CONSORT Statement as a way of improving the evidence base in pediatric psychology. Journal of Pediatric Psychology. 2003, 28(3):169-171.